GENESIS BIOPHARMA

genesis-biopharma-logo

Genesis Biopharma, Inc. Merge with Lion Biotechnologies, Inc. Genesis Biopharma, Inc. (OTCBB: GNBP) is developing autologous cell therapies for the treatment of cancer. Our lead product candidate, Cลntegoโ„ข, is an autologous cell therapy using tumor infiltrating lymphocytes (TILs) indicated for the treatment of metastatic melanoma. Cลntegoโ„ข is being developed as a ready-to-infuse autologous cell therapy product. Following resection of the patientโ€™s tumor, TILs are isolated from th... e resected tumor, and expanded in vitro to several billion cells. The expanded TILs are then infused into the patient where they attack the melanoma tumors regardless of their location in the body. Cลntegoโ„ข is based on the adoptive cell therapy regimen using tumor infiltrating lymphocytes invented by Dr. Steven A. Rosenberg, Chief, Surgery Branch, Center for Cancer Research, National Cancer Institute for the treatment of metastatic melanoma. Dr. Rosenbergโ€™s adoptive cell therapy is presently available as a physician-sponsored investigational therapy for the treatment of Stage IV metastatic melanoma at the National Cancer Institute, MD Anderson Cancer Center, and the H. Lee Moffitt Cancer & Research Institute.

#SimilarOrganizations #People #Website #More

GENESIS BIOPHARMA

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
1997-01-01

Address:
Los Angeles, California, United States

Country:
United States

Website Url:
http://www.genesis-biopharma.com

Total Employee:
11+

Status:
Closed

Contact:
(866)963-2220

Total Funding:
7.74 M USD

Technology used in webpage:
Domain Not Resolving Google Analytics Classic Google Analytics Anonymize IP


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Employees Featured

not_available_image

Anthony Cataldo
Anthony Cataldo Director @ Genesis Biopharma
Director

not_available_image

Michael Handelman
Michael Handelman CFO & Director @ Genesis Biopharma
CFO & Director

Stock Details


Company's stock symbol is NASDAQ:IOVA

Official Site Inspections

http://www.genesis-biopharma.com

Unable to get host informations!!!

Loading ...

More informations about "Genesis Biopharma" on Search Engine